PRCT PROCEPT BIOROBOTICS CORP revenue, earnings and financials

For the quarter ended June 30, 2026, PROCEPT BIOROBOTICS CORP reported revenue of $94.5M (up 19.3% from a year earlier), net income of −$26.9M and diluted EPS of −$0.47; over the last four quarters revenue was $337M and net income −$14.3M; for the fiscal year ended December 2025 revenue was $308M, up 37.2% on the year before.

PRCT annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $308M, gross profit $196M, operating income −$104M, net income −$95.6K (margin 0.0%), EPS −$1.72
• Fiscal year ended Dec 2024: revenue $224M, gross profit $137M, operating income −$96.6M, net income −$91.4K (margin 0.0%), EPS −$1.75
• Fiscal year ended Dec 2023: revenue $136M, gross profit $71.0M, operating income −$109M, net income −$106K (margin -0.1%), EPS −$2.24
• Fiscal year ended Dec 2022: revenue $75.0M, gross profit $37.1M, operating income −$80.7M, net income −$87.2K (margin -0.1%), EPS −$1.96
• Fiscal year ended Dec 2021: revenue $34.5M, gross profit $15.9M, operating income −$54.2M, net income −$59.9K (margin -0.2%), EPS −$3.63

PRCT quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $94.5M (up 19.3% year over year), net income −$26.9M, EPS −$0.47
• Quarter ended Mar 31, 2026: revenue $83.1M (up 20.2% year over year), net income −$31.6M, EPS −$0.56
• Quarter ended Dec 31, 2025 (from the annual report): revenue $76.4M (up 11.9% year over year), net income $65.6M, EPS −$0.54
• Quarter ended Sep 30, 2025: revenue $83.3M (up 42.8% year over year), net income −$21.4M, EPS −$0.38
• Quarter ended Jun 30, 2025: revenue $79.2M (up 48.4% year over year), net income −$19.6M, EPS −$0.35
• Quarter ended Mar 31, 2025: revenue $69.2M (up 55.3% year over year), net income −$24.7M, EPS −$0.45
• Quarter ended Dec 31, 2024 (from the annual report): revenue $68.2M (up 56.6% year over year), net income $72.5M, EPS −$0.34
• Quarter ended Sep 30, 2024: revenue $58.4M (up 66.3% year over year), net income −$21.0M, EPS −$0.40
• Quarter ended Jun 30, 2024: revenue $53.4M (up 61.2% year over year), net income −$25.6M, EPS −$0.50
• Quarter ended Mar 31, 2024: revenue $44.5M (up 82.5% year over year), net income −$26.0M, EPS −$0.51
• Quarter ended Dec 31, 2023 (from the annual report): revenue $43.6M (up 83.3% year over year), net income $78.3M, EPS −$0.54
• Quarter ended Sep 30, 2023: revenue $35.1M (up 72.5% year over year), net income −$24.6M, EPS −$0.51
• Quarter ended Jun 30, 2023: revenue $33.1M (up 98.3% year over year), net income −$25.3M, EPS −$0.56
• Quarter ended Mar 31, 2023: revenue $24.4M (up 71.9% year over year), net income −$28.5M, EPS −$0.63
• Quarter ended Dec 31, 2022 (from the annual report): revenue $23.8M (up 134.6% year over year), net income $58.9M, EPS −$0.63
• Quarter ended Sep 30, 2022: revenue $20.3M (up 134.8% year over year), net income −$22.6M, EPS −$0.51
• Quarter ended Jun 30, 2022: revenue $16.7M (up 96.9% year over year), net income −$19.2M, EPS −$0.43
• Quarter ended Mar 31, 2022: revenue $14.2M (up 97.4% year over year), net income −$17.2M, EPS −$0.39
• Quarter ended Dec 31, 2021 (from the annual report): revenue $10.1M, net income $41.4M, EPS $2.84
• Quarter ended Sep 30, 2021: revenue $8.67M, net income −$14.1M, EPS −$1.22

PRCT cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$49.0M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$99.2M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$108M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$80.4M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$57.3M, share buybacks n/a

PRCT balance sheet

• Jun 30, 2026: cash $228M, total assets $479M, total liabilities $139M, shareholders' equity $340M, long-term debt $51.7M
• Mar 31, 2026: cash $246M, total assets $487M, total liabilities $139M, shareholders' equity $348M, long-term debt $51.7M
• Dec 31, 2025: cash $287M, total assets $508M, total liabilities $142M, shareholders' equity $366M, long-term debt $51.6M
• Sep 30, 2025: cash $294M, total assets $512M, total liabilities $131M, shareholders' equity $380M, long-term debt $51.6M
• Jun 30, 2025: cash $303M, total assets $513M, total liabilities $127M, shareholders' equity $386M, long-term debt $51.5M
• Mar 31, 2025: cash $316M, total assets $519M, total liabilities $130M, shareholders' equity $389M, long-term debt $51.5M
• Dec 31, 2024: cash $334M, total assets $534M, total liabilities $132M, shareholders' equity $402M, long-term debt $51.5M
• Sep 30, 2024: cash $197M, total assets $374M, total liabilities $133M, shareholders' equity $241M, long-term debt $51.4M

What is PRCT's revenue?

PROCEPT BIOROBOTICS CORP reported $337M of revenue over its last four quarters, through June 30, 2026.

Is PRCT profitable?

No. PROCEPT BIOROBOTICS CORP lost $14.3M over the last four quarters.

What is PRCT's EPS?

Diluted earnings per share over the last four quarters were −$1.95; −$0.47 in the latest quarter.

PRCT ownership and insider trades · All stocks